🔗 References (max. 100)

show query show view
part subject predicate object published by date
Assertion
Assertion
These findings suggest that if ketamine is to find a place as an off-label treatment for depression and suicidality in mainstream psychiatry, researchers should study the safety, efficacy, and optimization of oral ketamine. Intravenous and intranasal routes may be monetarily more promising, but the oral route could be of greatest service.
Assertion
Assertion
Assertion
Assertion
Assertion
Assertion
Assertion
Assertion